برای نمایش بهتر وب سایت از ورژن جدید مرورگر فایرفاکس یا گوگل کروم استفاده نمایید.

دانلود ورژن جدید فایرفاکس دانلود ورژن جدید کروم

Competing interests

A competing interest exists when professional judgment concerning a primary interest (such as patients’ welfare or the validity of research) may be influenced by a secondary interest (such as financial gain - employment, consultancies, stock ownership or options, honoraria, patents, and paid expert- testimony or personal relationship). There is nothing unethical about a competing interest but it should be acknowledged and clearly stated. All authors must declare all competing interests in their covering letter and in “Competing Interests” section at the end of the manuscript file (before the references). Authors with no competing interests to declare should obviously state that.

The policy of Tabriz University of Medical Sciences is that none of the editors should have any financial relationship with any biomedical company.

Ethical approval of research/Publication Ethics

Tabriz University of Medical Sciences journals are following of the Committee on Publication Ethics (COPE) and aim to adhere to its Best Practice Guidelines.

We strongly consider allegations of publication misconduct, both before and after publication, and we reserve the right to contact authors' institutions, funders, or regulatory bodies if needed. If we find conclusive evidence of misconduct, we will take steps to correct the scientific record, which may include supplying a correction or retraction.

Authors are expected to be aware of publication ethics, specifically with regard to authorship, dual submission, plagiarism, figure manipulation, competing interests, and compliance with standards of research ethics. In cases of suspected misconduct, we will follow COPE standards and practices and may seek advice from the COPE forum if needed.

Statement of Ethics Approval

We require every research article submitted to include a statement that the study obtained ethics approval (or a statement that it was not required and why), including the name of the ethics committee(s) or institutional review board(s), the number/ID of the approval(s), and a statement that participants gave informed consent before taking part. Even when a study has been approved by a research ethics committee or institutional review board, editors may ask authors for more detailed information about the ethics of the work.

Patient consent and confidentiality

Any article that contains personal medical information about an identifiable living individual requires the patient’s explicit consent before we can publish it. We would like the patient to sign our consent form, which requires the patient to have read the article.

If consent cannot be obtained because the patient cannot be traced then publication will be possible only if the information can be sufficiently anonymized. Anonymisation means that neither the patient nor anyone else could identify the patient with certainty.

If the patient is dead the authors should seek permission from a relative (as a matter of courtesy and medical ethics). If the relatives are not contactable we will balance the worthwhileness of the case, the likelihood of identification, and the likelihood of offence if identified in making a decision on whether we should publish without a relative’s consent.

Our policy on obtaining consent for publication of pictures of patients is a subset of our general policy on patient confidentiality. If there is any chance that a patient may be identified from a photograph or other image or from its legend or accompanying text we need the patient’s written consent to publication by Tabriz University of Medical Sciences.

Images – such as x rays, laparoscopic images, ultrasound images, pathology slides, or images of undistinctive parts of the body – may be used without consent so long as they are anonymized by the removal of any identifying marks and are not accompanied by text that could reveal the patient’s identity through clinical or personal detail.

Research reporting guidelines

Authors are encouraged to use the relevant research reporting guidelines for the study type provided by the EQUATOR Network. This will ensure that you provide enough information for editors, peer reviewers and readers to understand how the research was performed and to judge whether the findings are likely to be reliable.

The key reporting guidelines are:

Clinical trial registration

Based on ICMJE recommendations, a clinical trial defines as “any research project that prospectively assigns people or a group of people to an intervention, with or without concurrent comparison or control groups, to study the cause-and-effect relationship between a health-related intervention and a health outcome”.

In agreement with the ICMJE , journals published by Tabriz University of Medical Sciences will not consider reports of clinical trials unless they were registered prospectively before recruitment of any participants.

Trial Registration

As a condition of consideration for publication, journals published by Tabriz University of Medical Sciences require registration of all trials in a public trials registry that is acceptable to the ICMJE (any registry that is a primary register of the WHO International Clinical Trials Registry Platform www.who.int/ictrp /network/primary/en/index.html or in ClinicalTrials.gov, which is a data provider to the WHO ICTRP).

Plagiarism detection

Journals published by Tabriz University of Medical Sciences use iThenticate software, which is a plagiarism detector service that verifies the originality of content submitted before publication. If plagiarism is identified, we will follow COPE guidelines.

Plagiarism includes, but is not limited to:

  • Directly copying text from other sources
  • Copying ideas, images, or data from other sources
  • Reusing text from your own previous publications
  • Using an idea from another source with slightly modified language

If plagiarism is detected during the peer review process, the manuscript may be rejected. If plagiarism is detected after publication, we reserve the right to issue a correction or retract the paper, as appropriate. We reserve the right to inform authors' institutions about plagiarism detected either before or after publication.